热门资讯> 正文

MAIA生物科技宣布董事以私募方式购买股份

2024-04-30 20:39

MAIA Biotechnology (NYSE:MAIA) announced that independent director Adelina Louie Ngar Yee made an individual purchase of 19,665 shares, and warrants for 19,665 shares, of MAIA’s common stock as part of recent private placement.
The securities sold to the company directors participating in the offering were issued pursuant to the company’s 2021 Equity Incentive Plan.
Source: Press Release

More on MAIA Biotechnology

MAIA Biotechnology announces share purchase by director Stan Smith in private placement
MAIA Biotechnology announces $1M private placement
Seeking Alpha’s Quant Rating on MAIA Biotechnology
Historical earnings data for MAIA Biotechnology
Financial information for MAIA Biotechnology

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。